Characteristics of women on opioid substitution therapy in primary healthcare in Tshwane (South Africa): a retrospective observational study
- PMID: 39168495
- PMCID: PMC12137995
- DOI: 10.3399/BJGPO.2024.0049
Characteristics of women on opioid substitution therapy in primary healthcare in Tshwane (South Africa): a retrospective observational study
Abstract
Background: Women who use drugs face specific challenges compared with men such as higher rates of HIV infection, unsafe injecting practices, and intimate partner violence (IPV). However, this population's access to drug dependence treatment and gender-sensitive interventions remains limited, leading to unmet needs and increased vulnerability.
Aim: To investigate the characteristics of and associations with retention in care among women on opioid substitution therapy (OST) in a community-based primary care setting.
Design & setting: A descriptive observational study within the Community Orientated Substance Use Programme in Tshwane, South Africa.
Method:
Data from 199 women (aged
Results: The majority of participants were unemployed, with 44.3% aged 20-29 years. During the initiation and course of OST, 39.2% of women had an intimate partner of which 37.2% reported IPV, and 19.2% were pregnant. Retention on OST was significantly associated with increasing age at initiation (P = 0.047), knowledge of HIV status (P = 0.029), an increase in the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) score (P = 0.023), and methadone dose (P<0.001). Factors such as race, employment status, health-system level, pregnancy, intimate partner using substances, IPV, route of administering opioids, and having tuberculosis and/or hepatitis C exposure did not show a significant relationship with retention on OST (P>0.05).
Conclusion: This study reveals specific vulnerabilities in women receiving OST, emphasising the need for the integration of interventions to address reproductive health, violence mitigation, infectious disease, and polydrug use into care.
Keywords: community based primary care; harm reduction; opiate substitution treatment; primary health care.
Copyright © 2025, The Authors.
Conflict of interest statement
The authors declare that no competing interests exist.
Similar articles
-
Retention of service users on opioid substitution therapy in the City of Tshwane, South Africa.Afr J Prim Health Care Fam Med. 2023 Jan 30;15(1):e1-e10. doi: 10.4102/phcfm.v15i1.3392. Afr J Prim Health Care Fam Med. 2023. PMID: 36744456 Free PMC article.
-
Factors predicting 6-month retention among people with opioid use disorders accessing outpatient methadone maintenance therapy in Tshwane, South Africa.S Afr Med J. 2020 Dec 14;111(1):68-73. doi: 10.7196/SAMJ.2020.v111i1.14884. S Afr Med J. 2020. PMID: 33404009
-
'I went for rehab many times and it never worked, but the harm reduction process has given me renewed hope'. Perceptions on the effectiveness of harm reduction and community-based opioid substitution therapy.Health Promot J Austr. 2024 Jul;35(3):653-661. doi: 10.1002/hpja.789. Epub 2023 Aug 22. Health Promot J Austr. 2024. PMID: 37605794
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
A systematic review of the effects of intimate partner violence on HIV-positive pregnant women in sub-Saharan Africa.BMC Public Health. 2022 Feb 3;22(1):220. doi: 10.1186/s12889-022-12619-w. BMC Public Health. 2022. PMID: 35114964 Free PMC article.
References
-
- United Nations Office on Drugs and Crime World Drug Report 2021. 2021. https://www.unodc.org/unodc/en/data-and-analysis/wdr2021.html. [5 Nov 2024]. https://www.unodc.org/unodc/en/data-and-analysis/wdr2021.html accessed.
-
- Dada S, Harker Burnhams N, Erasmus J, Lucas Charles Parry W, et al. South African community epidemiology network on drug use. SACENDU Report. 2020. https://www.samrc.ac.za/sites/default/files/attachments/2022-07/SACENDUF.... [12 Jan 2025]. https://www.samrc.ac.za/sites/default/files/attachments/2022-07/SACENDUF... accessed.
-
- Degenhardt L, Peacock A, Colledge S, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017; 5 (12):e1192–e1207. doi: 10.1016/S2214-109X(17)30375-3. - DOI - PMC - PubMed
-
- The Global Fund Technical brief: Harm reduction for people who use drugs — priorities for investment and increased impact in HIV programming. Allocation period 2023–2025. 2022. https://www.theglobalfund.org/media/1279/core_harmreduction_infonote_en.pdf. [5 Nov 2024]. https://www.theglobalfund.org/media/1279/core_harmreduction_infonote_en.pdf accessed.
-
- South African National AIDS Council Midterm Review of the National Strategic Plan for HIV, TB and STIs 2017–2022. 2019. https://sanac.org.za/wp-content/uploads/2021/05/MTR-Summary-Report-NSP-F.... [12 Jan 2025]. https://sanac.org.za/wp-content/uploads/2021/05/MTR-Summary-Report-NSP-F... accessed.
LinkOut - more resources
Full Text Sources